Cargando…
Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer
Long, noncoding RNAs (lncRNAs) are indispensable for normal cell physiology and, consequently, are tightly regulated in human cells. Yet, unlike mRNA, substantially less is known about the mechanisms for lncRNA degradation. It is important to delineate the regulatory control of lncRNA degradation, p...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605189/ https://www.ncbi.nlm.nih.gov/pubmed/37887339 http://dx.doi.org/10.3390/cells12202495 |
_version_ | 1785127013771640832 |
---|---|
author | Quttina, Maram Waiters, Kacie D. Khan, Ashfia Fatima Karami, Samaneh Peidl, Anthony S. Babajide, Mariam Funmi Pennington, Justus Merchant, Fatima A. Bawa-Khalfe, Tasneem |
author_facet | Quttina, Maram Waiters, Kacie D. Khan, Ashfia Fatima Karami, Samaneh Peidl, Anthony S. Babajide, Mariam Funmi Pennington, Justus Merchant, Fatima A. Bawa-Khalfe, Tasneem |
author_sort | Quttina, Maram |
collection | PubMed |
description | Long, noncoding RNAs (lncRNAs) are indispensable for normal cell physiology and, consequently, are tightly regulated in human cells. Yet, unlike mRNA, substantially less is known about the mechanisms for lncRNA degradation. It is important to delineate the regulatory control of lncRNA degradation, particularly for lncRNA telomeric repeat-containing RNA (TERRA), as the TERRA-telomere R-loops dictate cell cycle progression and genomic stability. We now report that the exosome complex component Exosc9 degrades lncRNA TERRA in human mammary epithelial cells. Heterochromatin protein 1 alpha (HP1α) recruits Exosc9 to the telomeres; specifically, the SUMO-modified form of HP1α supports interaction with Exosc9 and, as previously reported, lncRNA TERRA. The telomeric enrichment of Exosc9 is cell cycle-dependent and consistent with the loss of telomeric TERRA in the S/G2 phase. Elevated Exosc9 is frequently observed and drives the growth of endocrine therapy-resistant (ET-R) HR+ breast cancer (BCa) cells. Specifically, the knockdown of Exosc9 inversely impacts telomeric R-loops and the integrity of the chromosome ends of ET-R cells. Consistently, Exosc9 levels dictate DNA damage and the sensitivity of ET-R BCa cells to PARP inhibitors. In this regard, Exosc9 may serve as a promising biomarker for predicting the response to PARP inhibitors as a targeted monotherapy for ET-R HR+ BCa. |
format | Online Article Text |
id | pubmed-10605189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-106051892023-10-28 Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer Quttina, Maram Waiters, Kacie D. Khan, Ashfia Fatima Karami, Samaneh Peidl, Anthony S. Babajide, Mariam Funmi Pennington, Justus Merchant, Fatima A. Bawa-Khalfe, Tasneem Cells Article Long, noncoding RNAs (lncRNAs) are indispensable for normal cell physiology and, consequently, are tightly regulated in human cells. Yet, unlike mRNA, substantially less is known about the mechanisms for lncRNA degradation. It is important to delineate the regulatory control of lncRNA degradation, particularly for lncRNA telomeric repeat-containing RNA (TERRA), as the TERRA-telomere R-loops dictate cell cycle progression and genomic stability. We now report that the exosome complex component Exosc9 degrades lncRNA TERRA in human mammary epithelial cells. Heterochromatin protein 1 alpha (HP1α) recruits Exosc9 to the telomeres; specifically, the SUMO-modified form of HP1α supports interaction with Exosc9 and, as previously reported, lncRNA TERRA. The telomeric enrichment of Exosc9 is cell cycle-dependent and consistent with the loss of telomeric TERRA in the S/G2 phase. Elevated Exosc9 is frequently observed and drives the growth of endocrine therapy-resistant (ET-R) HR+ breast cancer (BCa) cells. Specifically, the knockdown of Exosc9 inversely impacts telomeric R-loops and the integrity of the chromosome ends of ET-R cells. Consistently, Exosc9 levels dictate DNA damage and the sensitivity of ET-R BCa cells to PARP inhibitors. In this regard, Exosc9 may serve as a promising biomarker for predicting the response to PARP inhibitors as a targeted monotherapy for ET-R HR+ BCa. MDPI 2023-10-20 /pmc/articles/PMC10605189/ /pubmed/37887339 http://dx.doi.org/10.3390/cells12202495 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Quttina, Maram Waiters, Kacie D. Khan, Ashfia Fatima Karami, Samaneh Peidl, Anthony S. Babajide, Mariam Funmi Pennington, Justus Merchant, Fatima A. Bawa-Khalfe, Tasneem Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer |
title | Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer |
title_full | Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer |
title_fullStr | Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer |
title_full_unstemmed | Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer |
title_short | Exosc9 Initiates SUMO-Dependent lncRNA TERRA Degradation to Impact Telomeric Integrity in Endocrine Therapy Insensitive Hormone Receptor-Positive Breast Cancer |
title_sort | exosc9 initiates sumo-dependent lncrna terra degradation to impact telomeric integrity in endocrine therapy insensitive hormone receptor-positive breast cancer |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605189/ https://www.ncbi.nlm.nih.gov/pubmed/37887339 http://dx.doi.org/10.3390/cells12202495 |
work_keys_str_mv | AT quttinamaram exosc9initiatessumodependentlncrnaterradegradationtoimpacttelomericintegrityinendocrinetherapyinsensitivehormonereceptorpositivebreastcancer AT waiterskacied exosc9initiatessumodependentlncrnaterradegradationtoimpacttelomericintegrityinendocrinetherapyinsensitivehormonereceptorpositivebreastcancer AT khanashfiafatima exosc9initiatessumodependentlncrnaterradegradationtoimpacttelomericintegrityinendocrinetherapyinsensitivehormonereceptorpositivebreastcancer AT karamisamaneh exosc9initiatessumodependentlncrnaterradegradationtoimpacttelomericintegrityinendocrinetherapyinsensitivehormonereceptorpositivebreastcancer AT peidlanthonys exosc9initiatessumodependentlncrnaterradegradationtoimpacttelomericintegrityinendocrinetherapyinsensitivehormonereceptorpositivebreastcancer AT babajidemariamfunmi exosc9initiatessumodependentlncrnaterradegradationtoimpacttelomericintegrityinendocrinetherapyinsensitivehormonereceptorpositivebreastcancer AT penningtonjustus exosc9initiatessumodependentlncrnaterradegradationtoimpacttelomericintegrityinendocrinetherapyinsensitivehormonereceptorpositivebreastcancer AT merchantfatimaa exosc9initiatessumodependentlncrnaterradegradationtoimpacttelomericintegrityinendocrinetherapyinsensitivehormonereceptorpositivebreastcancer AT bawakhalfetasneem exosc9initiatessumodependentlncrnaterradegradationtoimpacttelomericintegrityinendocrinetherapyinsensitivehormonereceptorpositivebreastcancer |